research use only

Aloxistatin (E64d) Cysteine Protease inhibitor

Cat.No.S7393

Aloxistatin (E64d) is an irreversible and membrane-permeable cysteine protease inhibitor with blood platelet aggregation inhibiting activity. This compound reduced cellular entry of SARS-CoV-2 pseudovirions by 92.3%, as the cysteine protease cathepsin L is required for SARS-CoV-2 viral entry.
Aloxistatin (E64d) Cysteine Protease inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 342.43

Quality Control

Cell Culture, Treatment & Working Concentration

Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
U937 cells Function assay Blockade of cathepsin G processing in human U937 cells by densitometry, IC50=1.1 μM 17535802
Click to View More Cell Line Experimental Data

Chemical Information, Storage & Stability

Molecular Weight 342.43 Formula

C17H30N2O5

Storage (From the date of receipt)
CAS No. 88321-09-9 Download SDF Storage of Stock Solutions

Synonyms E-64d Smiles CCOC(=O)C1C(O1)C(=O)NC(CC(C)C)C(=O)NCCC(C)C

Solubility

In vitro
Batch:

DMSO : 68 mg/mL (198.58 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 68 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
Cysteine protease [1]
In vitro

Aloxistatin (E64d) can enter the intact platelet and inhibit proteolysis by inhibiting calpain. [2]

It blunts Parathyroid hormone (PTH)-induced cell proliferation and inhibits differentiation osteoblasts in vitro. [3]

In vivo

Aloxistatin (E64d) (100 mg/kg, p.o.) strongly inhibits the cathepsin B&L activities in the skeletal muscle, heart and liver of hamsters. [1]

In spinal cord injury (SCI) rats, it provides neuroprotection in SCI lesion and penumbra. [4]

This compound reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B activity. [5]

References
  • [4] https://pubmed.ncbi.nlm.nih.gov/11462799/
  • [5] https://pubmed.ncbi.nlm.nih.gov/21613740/
  • [6] https://pubmed.ncbi.nlm.nih.gov/35974017/

Applications

Methods Biomarkers Images PMID
Western blot LAMP-1 / Rab5 / pro-Ctsl / Ctsl / Ctsb / pro-Ctsd S7393-WB1 25744631
Immunofluorescence LAMP-1 S7393-IF1 25744631

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.